Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Gibco™ HAT Supplement (50X)
GREENER_CHOICE

Catalog No. 21060017
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
21-060-017 100 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 21-060-017 Supplier Gibco™ Supplier No. 21060017
Only null left
Add to Cart
Edge
Add to Cart

HAT-supplemented medium is suitable for post-fusion selection against unfused or self-fused HGPRT-myeloma cells

  • Liquid mixture of sodium hypoxanthine (5mM), aminopterin (20μM) and thymidine (0.8mM)
  • Hypoxanthine and thymidine supply preformed purines and pyrimidines for DNA synthesis by hybridomas via the salvage pathway that utilizes HGPRT contributed by the fused spleen cell
  • Aminopterin, a folic acid antagonist, inhibits the de novo nucleoside biosynthesis pathway

Cell Culture, Mammalian Cell Culture

Order Info

Shipping Condition: Dry Ice

TRUSTED_SUSTAINABILITY

Specifications

Content And Storage Storage conditions: -5 to -20°C
Shipping conditions: Dry ice
Shelf life: 14 months from date of manufacture
Cell Type Mammalian Cells
Concentration 50 X
Form Liquid
Product Type HT Supplement
Sterility Sterile-filtered
pH 6 to 8
Quantity 100 mL
Shipping Condition Dry Ice
WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov

For Research Use Only. Not for use in diagnostic procedures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.